The April 2014 issue of the Canadian Adverse Reaction Newsletter published by the Marketed Health Products Directorate, Health Products and Food Branch is now available. This newsletter provides regular feedback to health professionals on adverse reactions reported in Canada.
In this issue:
- Quetiapine and acute liver failure
- Azithromycin and drug reaction with eosinophilia and systemic symptoms
- Clopidogrel and acquired hemophilia
For a complete listing, please go to http://www.health.gc.ca/carn.
